Unmasking IgAN: Achieving Earlier Diagnosis
Jonathan Barratt, MD, PhD
An De Vriese, MD, PhD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Translating Evidence into IgAN Care
Jörg Latus, MD
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Reading Between the Lines: What PROMs Reveal About Itch
Itching for Answers: Holistic CKD-aP Care
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Sayna Norouzi, MD
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Crossing Home Plate – Building a Winning Team Culture
ASCVD Playbook | Closing the Gaps, One Inning at a Time
Swing for the Fences – LDL-C as the Power Hitter
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Claudia Seikrit, MD